Theophylline Toxicity in Emergency Medicine Treatment & Management

  • Author: Greg Hymel, MD; Chief Editor: Asim Tarabar, MD   more...
 
Updated: Jul 12, 2011
 

Prehospital Care

  • Establish airway, breathing, and circulation (ABCs).
  • Intravenous benzodiazepines may abort seizures.
Next

Emergency Department Care

Evaluate ABCs and, if indicated, perform endotracheal intubation.

Vascular access for hemoperfusion may be required.

Endotracheal intubation may be needed in patients who require high-dose benzodiazepines or barbiturates to control seizures.

Consider gastric lavage (unless contraindicated) if the patient has recently (< 1 h) ingested a significant amount or a sustained-release preparation of theophylline or if theophylline bezoar formation is suspected. Gastric lavage should be considered in intubated patients. Endoscopic bezoar fragmentation and retrieval may be utilized if lavage is not efficacious.

Administer activated charcoal. Multidose activated charcoal (MDAC) enhances elimination of theophylline. It is a very effective method of elimination, and it is considered the mainstay treatment of theophylline toxicity. It is important to aggressively control nausea and vomiting in order to perform MDAC treatment. It is also important that the patient is able to protect his or her airway in order to prevent aspiration of activated charcoal, which can be detrimental. Administer the cathartic, sorbitol, with the activated charcoal one time.

Perform whole-bowel irrigation (WBI) in patients with exposure to sustained-release theophylline preparations.

Administer polyethylene glycol electrolyte solution.

  • Adults: 2 liters per hour until clear rectal effluent
  • Children: 500 mL/h until clear rectal effluent

Theophylline-induced seizures tend to be resistant to treatment. Benzodiazepines (eg, lorazepam) are considered the first line of treatment. Historically, phenobarbital prophylaxis was used in patients at high risk for seizures. High-risk cases include the following:

  • Acute overdose with theophylline levels higher than 80 mcg/mL
  • Chronic toxicity with levels higher than 40 mcg/mL
  • Patients older than 60 years or younger than 3 years

Benzodiazepines (IV) and phenobarbital may be used to treat seizures.

  • CAVEAT: Barbiturates can precipitate hypotension.
  • Phenobarbital has the added advantage of enhancing the hepatic metabolism of theophylline.

Hypotension resistant to isotonic fluids (10-20 mL/kg) may require vasopressors with predominantly alpha-agonistic activity (eg, phenylephrine, norepinephrine). In patients with theophylline toxicity, beta-blockade with propranolol has been shown to successfully reverse peripheral beta receptor-mediated hypotension without apparent effect on concomitant tachycardia. However, always consider the risk of beta-adrenergic blockade to patients with preexistent bronchospastic disease.

Esmolol, a short-acting beta-blocker, has been used successfully for unstable SVT and related hypotension in theophylline overdose.[2] Exercise caution with beta-blocking agents because of their negative inotropic effects. Esmolol is a relatively selective beta1-receptor antagonist; thus, it may not have as much effect on beta2-mediated hypotension as less-selective agents (eg, propranolol), although it is less likely to induce bronchospasm than other beta-blockers.

Consider hemoperfusion with the following:

  • Symptomatic patients with levels exceeding 90 mcg/mL in acute ingestions
  • Theophylline concentrations exceeding 40 mcg/mL (chronic ingestion)
  • Presence of life-threatening toxicity
  • Persistent seizures
  • Hypotension that is not responding to IV fluids
  • Ventricular dysrhythmia

Hemodialysis is an alternative method of elimination enhancement but is considerably less effective than hemoperfusion.

Correct electrolyte abnormalities in patients with ECG changes (eg, QTc prolongation) and/or ventricular dysrhythmias.

  • Hypocalcemia
  • Hypophosphatemia
  • Hypokalemia

Current recommendations for treating patients with tachycardia, hypotension, anxiety, and vomiting from theophylline overdose may include the following:

  • Fluid bolus with isotonic fluid (20 mL/kg)
  • Metoclopramide or ondansetron to help control vomiting
  • Propranolol to increase blood pressure - Reportedly propranolol treatment can correct hypokalemia.[3]
  • Benzodiazepine to decrease anxiety, decrease risk of seizures, and help control vomiting
  • Phenylephrine or norepinephrine to further increase blood pressure
  • Charcoal hemoperfusion guided by response to treatment, underlying medical problems, and theophylline level: Because charcoal hemoperfusion is a somewhat complicated process that is not routinely used lately, most of the centers will perform routine hemodialysis. Hemodialysis in combination with MDAC will most of the time be sufficient for the treatment of severe theophylline toxicity.
Previous
Next

Consultations

  • Consult the regional poison control center or local medical toxicologist (certified through the American Board of Medical Toxicology or the American Board of Emergency Medicine) for additional information and patient care recommendations.
  • Consult a nephrologist if hemoperfusion is needed.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Greg Hymel, MD  Assistant Medical Director, Department of Emergency Medicine, Mercy Saint Vincent Medical Center

Greg Hymel, MD is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians

Disclosure: Nothing to disclose.

Specialty Editor Board

Lance W Kreplick, MD, FAAEM, MMM  Medical Director of Hyperbaric Medicine, Fawcett Wound Management and Hyperbaric Medicine; Consulting Staff in Occupational Health and Rehabilitation, Company Care Occupational Health Services; President and Chief Executive Officer, QED Medical Solutions, LLC

Lance W Kreplick, MD, FAAEM, MMM, is a member of the following medical societies: American Academy of Emergency Medicine and American College of Physician Executives

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD  Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

Fred Harchelroad, MD, FACMT, FAAEM, FACEP  Director of Medical Toxicology, Allegheny General Hospital

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD  Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

References
  1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila). Dec 2010;48(10):979-11178. [Full Text].

  2. Seneff M, Scott J, Friedman B, Smith M. Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability. Ann Emerg Med. Jun 1990;19(6):671-3. [Medline].

  3. Kearney TE, Manoguerra AS, Curtis GP, Ziegler MG. Theophylline toxicity and the beta-adrenergic system. Ann Intern Med. Jun 1985;102(6):766-9. [Medline].

  4. Brashear RE, Aronoff GR, Brier RA. Activated charcoal in theophylline intoxication. J Lab Clin Med. Sep 1985;106(3):242-5. [Medline].

  5. Charytan D, Jansen K. Severe metabolic complications from theophylline intoxication. Nephrology (Carlton). Oct 2003;8(5):239-42. [Medline].

  6. Cooling DS. Theophylline toxicity. J Emerg Med. Jul-Aug 1993;11(4):415-25. [Medline].

  7. Gaudreault P, Harwood-Nuss. Methylxanthines, Toxicology. In: Clinical Practice of Emergency Medicine. 4th ed. 2005:1649-1652.

  8. Henderson A, Wright DM, Pond SM. Management of theophylline overdose patients in the intensive care unit. Anaesth Intensive Care. Feb 1992;20(1):56-62. [Medline].

  9. Kallstrom TJ. Evidence-based asthma management. Respir Care. Jul 2004;49(7):783-92. [Medline].

  10. Marshall H, Emerman CL, Tintinalli J. Theophylline, Toxicology and Pharmacology. In: Emergency Medicine, A Comprehensive Study Guide. 6th ed. 2004:1098-1101.

  11. Medical Economics Staff. Drugs. In: Physician's Desk Reference. Medical Economics Co; 1997.

  12. Micromedex. Theophylline. In: Micromedex. 1974-2008:36.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.